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Purpose: Radiotherapy for head and neck cancer does not impair the voice quality 
as much as laser treatment or surgery, but it can induce muscle wasting and fibrosis 
and symptoms of dry mouth. We investigated the effect of irradiation on the myosin 
heavy chain (MyHC) expression in laryngeal muscles. Materials and Methods: 
Rats were irradiated with one dose of 10, 15, 20, 25, 30, or 35 Gy and other rats 
were irradiated with 20 Gy. The thyroarytenoid (TA), posterior cricoarytenoid 
(PCA), and cricothyroid (CT) muscles were subjected to reverse transcription-poly-
merase chain reaction (RT-PCR). Results: Two weeks after irradiation with 10, 15, 
or 20 Gy, all the MyHC type expressions had decreased in a dose-dependent man-
ner in the TA, PCA, and CT muscles, and especially the expression of MyHC IIa 
decreased much more than the expressions of the other MyHC isoforms in all mus-
cles. In the 20 Gy-irradiated rats, almost all the MyHC isoform expressions de-
clined over 12 weeks in the TA, PCA, and CT muscles, except for the MyHC I ex-
pression in the PCA and CT muscle. The MyHC IIa expression was markedly 
decreased in all the muscles. Conclusion: The laryngeal muscles responded differ-
ently to radiation, but they showed a time-dependent and long-lasting decrease in 
the expressions of all the MyHC isoforms in the TA, PCA, and CT muscles. In par-
ticular, the expression of the MyHC IIa isoform in all the muscles may be more 
sensitive to irradiation than the expressions of the other MyHC isoforms. 
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INTRODUCTION
Early stage laryngeal cancer can be treated with radiation therapy or excision of 
the lesion with using a laser,1,2 but laser treatment generally negatively affects the 
voice quality because it removes part of the vocal cord. In contrast, radiation thera-
py, which completely cures 90% of the cases of early stage laryngeal cancer, gen-
erally well preserves the voice of the patient. However, some irradiated patients do 
experience voice changes because the radiation destroys the salivary gland, result-
ing in xerostomia, and the radiation causes muscle wasting and fibrosis and it may MyHC Expression Changes in the Larynx Muscle after RT
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sure: 3 days, 2 weeks, 4 weeks, and 12 weeks. Five rats of 
each group were also sacrificed by a barbiturate overdose to 
examine the effects of radiation on the body weight loss 
and the laryngeal muscles’ MyHC isoform expression.
 
Irradiation 
The head and neck areas of the rats were evenly irradiated 
with 2 Gy per minute by using a 6 MV energy therapeutic 
linear accelerator (CLINAC 600C, Varian, Palo Alto, CA, 
USA). To irradiate the head and neck area with a sufficient 
dose of radiation, a 1.0 cm bolus was used for increasing 
the radiation dose. A single dose of irradiation was adminis-
tered. To immobilize the animals during their irradiation, 
the rats were anesthetized with an intraperitoneal injection 
of ketamin hydrochloride (40 mg/kg) and xylazine hydro-
chloride (5 mg/kg). No side effects or complications oc-
curred during the rats’ anesthesia.
Determining the effect of different radiation doses on 
the MyHC isoform expressions  
Thirty-five rats were grouped into seven groups: the con-
trol group and the 10, 15, 20, 25, 30, and 35 Gy groups. 
Each group was composed of 5 rats. To immobilize the an-
imals during their irradiation, the rats were anesthetized 
with an intraperitoneal injection of ketamin hydrochloride 
(40 mg/kg) and xylazine hydrochloride (5 mg/kg). All the 
animals were sacrificed two weeks later with a barbiturate 
overdose. 
Determining the changes of the MyHC isoform 
expression over time after irradiation 
Twenty rats were equally grouped into four groups, and 
each group was irradiated with 20 Gy of X-ray. The rats in 
each group were anesthetized and sacrificed 3 days, 2 weeks, 
4 weeks, and 12 weeks later, respectively. In general, we 
examined MyHC types I, IIa, IIb, IIx, and IIL in the TA, 
PCA, and CT muscles. We did not examine the effect of ra-
diation on the TA expression of MyHC I because it has 
been reported that the TA muscle expresses very low levels 
of MyHC I.9 We also did not examine the expression of 
MyHC IIL in the CT muscle since its baseline expression 
of this isoform is very low.10
Extraction of RNA from the muscles and SYBR Green 
real time-RT-PCR 
After resection of the larynx from the sacrificed rats by us-
ing a surgical microscope, the TA, PCA, and CT muscles 
change the composition of the myosin heavy chain 
(MyHC) isoforms.3,4 There is currently a great deal of ac-
tive research on MyHC isoforms in the field of otorhinolar-
yngology.4-6 These studies have provided a good foundation 
for analyzing the changes of the laryngeal muscles’ expres-
sion of MyHC isoforms after irradiation.
MyHC is an important factor that controls the pattern of 
muscle contraction. There are a number of MyHC isoforms. 
Of these, MyHC type I is expressed in muscles with a slow 
contraction speed while MyHC type II is primarily involved 
in fast muscle contraction. In particular, MyHC type IIb is 
involved in very fast muscle contraction, although it is as-
sociated with a severe fatigue phenomenon. In contrast, IIa 
is involved in slower muscle contraction and it is associated 
with a less severe fatigue phenomenon, while IIx partici-
pates in intermediate muscle contraction.7,8 Furthermore, a 
recent study has shown that MyHC type IIeo, which is 
present in the extraocular muscles of the eye, is involved in 
the fastest muscle contraction.6
We examined the change in body weight and the change 
of the MyHC isoform expression in a murine model ac-
cording to different radiation doses and over time after irra-
diation. To accomplish this, the thyroarytenoid (TA), the 
posterior cricoarytenoid (PCA), and cricothyroid (CT) 
muscles of rats were dissected out and examined by SYBR 





Fifty-five Sprague-Dawley (SD) rats (Samtako Co., O San, 
Korea) (mean age: 7 to 8 weeks, mean weight: 220 ± 30 g) 
were maintained at three rats per cage and they were given 
free access to standard rat chow and water. The rats were 
kept at a room temperature of 23 ± 1°C and humidity of 55 
± 5%, with 12 hour lighting at 150-300 lux. 
Our experiment is composed of two subexperiments. In 
the first experiment, 35 rats were used, and these were di-
vided into seven groups according to a single radiation 
dose: the control (no radiation), 10 Gy, 15 Gy, 20 Gy, 25 
Gy, 30 Gy, and 35 Gy groups of 5 rats per group. The rats 
were sacrificed 2 weeks later after X-irradiation by a barbi-
turate overdose. In the second experiment, 20 rats were ex-
posed to 20 Gy, and they were divided into four groups of 5 
rats each according to the elapsed time after radiation expo-Jin Pyeong Kim, et al.
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er, and 2 µL cDNA and 11.6 µL DNase-RNase free water. 
For amplification, the reaction mixtures were placed on 32-
well optical reaction plates and 50 cycles were performed. 
After the last cycle, melting curve analysis was performed 
to examine whether the products were the correct products. 
The LightCycler® (LightCycler® FastStart DNA Master 
SYBR Green I) PCR parameters are as follows: preincuba-
tion at 95°C for 10 min, amplification, denaturation at 95°C 
for 10 sec, annealing at 58°C for 5 sec, and extension at 
72°C for 11 sec. The PCR parameters for the melting curve 
analysis are as follows: denaturation at 95°C for 0 sec, an-
nealing at 65°C for 15 sec, melting at 95°C for 0 sec, and 
cooling at 40°C for 30 sec.
Statistical analysis 
The comparative threshold method was applied to examine 
the effect of radiation on the MyHC expression in the la-
ryngeal muscles of the SD rats. This method assesses the 
relative expression of the gene of interest by determining 
the difference between the threshold cycles of the gene of 
interest and the housekeeping gene. GAPDH served as the 
housekeeping gene. The 2-ddCt method is well-known as a 
comparative threshold method and thus the following equa-
tion was used: ddCt = control group (Ct target-Ct reference) 
- irradiated group (Ct target-Ct reference). Two statistical 
analyses were performed for assessing the MyHC isoform 
expression. Paired t-tests with Bonferroni’s correction was 
used to analyze the effect of different radiation doses and 
over time in the each MyHC isoform, and repeated mea-
sures of ANOVA (post-hoc analysis by Turkey) were used 
to analyze the differences between the MyHC isoforms in 
each muscle. p values less than 0.05 were considered statis-
tically significant.
were removed and stored in a - 80°C freezer. The RNA was 
extracted on the same day.
The total RNA was extracted by using TRIzol® reagent 
(Invitrogen, Carlsbad, CA, USA) according to the method 
suggested by the manufacturer. The cDNA was synthesized 
from the RNA, by using Superscript III reverse transcrip-
tase (Invitrogen), and RT-PCR was performed in a total re-
action volume of 20 µL. In the first step, a mixture consist-
ing of 1 µL random hexomer, 1 µL oligo (dT) 18, 1 µL 10 
mM dNTP mix, 8 µL extracted total RNA and 2 µL DN-
ase-RNase free water was reacted for 5 minutes at 65°C 
and then it was cooled on ice for at least 1 minute. Thereaf-
ter, 4 µL of 5X first strand buffer, 1 µL of 0.1 M DDT, 1 µL 
Superscript III RT, and 1 µL RNase OUT (Invitrogen, Mad-
ison, WI, USA) were added. The mixture reacted at 25°C 
for 10 minutes, 42°C for 50 minutes, and 85°C for 5 min-
utes. The residual complementary RNA was removed by 
adding 1 µL containing 2 units of E. coli RNAse H (New 
England BioLabs, Ipswich, MA, USA). After a reaction at 
37°C for 20 minutes, the samples were stored at -20°C until 
use. The oligonucleotide primers for the MyHC type I, IIa, 
IIb, IIx, and IIL isoforms were synthesized (Table 1) by ap-
plying the Primer Express Program (Iowa city, IA, USA)
which was published by the NCBI, to the MyHC gene se-
quences of the SD rats. Primers for the housekeeping con-
trol gene, i.e., glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), were also used. All the primers we used were 
purchased from Bioneer Co. (Daejeon, Korea). Quantita-
tive PCR was performed by using LightCycler® Software 
Version 4.0 and the LightCycler® Instrument (Roche, 
Seoul, Korea). A 20 µL total volume was prepared with 2 
µL LightCycler® FastStart DNA Master SYBR Green I, 2.4 
µL 25 mM MgCl2, 1 µL of each forward and reverse prim-
Table 1. Oligonucleotide Sequences of the MyHC Isoform Primers
Isoform Forward primer Reverse primer
Accession number 
(NIH, USA in the NCBI)
Type I 
GAA TGG CAA GAC GGT
GAC TGT 




ATG ACA ACT CCT CTC
GCT TTG G
TTA AGC TGG AAA GTG
 ACC CGG 
xm_340817
Type IIb
GAA CAC GAA GCG TGT
CAT CCA




AAG AGA TGA CTT ACC
AGG CCG A
GCC TGC CTC TTG TAG
GAC TTC A 
xm_340820
Type IIx
CCA ATG AGA CTA AGA 
CGC CTG G
GCT ATC GAT GAA TTG
TCC CTC G 
xm_213345
GAPDH
TGC CGC CTG GAG AAA 
CCT GC
TGA GAG CAA TGC CAG
CCC CA
M17701
MyHC, myosin heavy chain; NIH, National Institutes of Health; NCBI, National Center for Biotechnology Information.MyHC Expression Changes in the Larynx Muscle after RT
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out separately and subjected to real time RT-PCR for as-
sessing the expressions of the MyHC I, IIa, IIb, IIx, and IIL 
isoforms. Of the rats irradiated with 10, 15, or 20 Gy, most 
of the MyHC isoform expressions clearly showed a dose-
dependent decrease, excluding the MyHC IIa expression in 
the TA and PCA muscles (Fig. 1). The statistical analysis 
using repeated measures of ANOVA (post-hoc analysis by 
Turkey) revealed that the MyHC IIa expression in particu-
lar significantly decreased, as compared to the expressions 
of the other MyHC isoforms, in all three muscles by 10 to 
20 Gy radiation (p < 0.05) (Table 2).
Effect of 20 Gy irradiation on the laryngeal muscles’ 
MyHC isoform expressions over time
The surviving 20 Gy-irradiated rats were examined 3 days 
or 2, 4, or 12 weeks after irradiation. The expression of al-
most all the MyHC isoforms by the TA, PCA, and CT mus-
cles gradually decreased over time, except the MyHC I ex-
pression in the PCA and CT muscles and the MyHC IIL 
RESULTS
Changes of the body weight 
The rats exposed to 10-20 Gy lost weight soon after irradia-
tion and they gradually recovered the weight lost. The rats 
exposed to 25 Gy or more radiation continuously lost 
weight before dying. In particular, the effect of 20 Gy radia-
tion on the living rats was the most severe. These rats could 
not see properly and they had trouble opening their mouth 
to eat, so all the rats exhibited weight loss during the first 
10 days of the experiment. However, they began to recover 
their weight after 2 weeks. The rats irradiated more than 20 
Gy died between days 7 and 12 and they could not partici-
pate in the remainder of the study.
Effect of different radiation doses on the laryngeal 
muscles’ MyHC isoform expressions



























































































































Fig. 1. MyHC isoform expression changes 2 weeks after irradiation with 10, 15, or 20 Gy. (A) Thyroarytenoid muscle. (B) Posterior cricoary-
tenoid muscle. (C) Cricothyroid muscle (Bar represent mean value and standard error of the mean, *paired t-test by bonferroni correction). 
MyHC, myosin heavy chain.
BJin Pyeong Kim, et al.
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Fig. 2. MyHC isoform expression changes 3 days or 2, 4, or 12 weeks after irradiation with 20 Gy. (A) Thyroarytenoid muscle. (B) Posterior cri-
coarytenoid muscle. (C) Cricothyroid muscle (Bar represent mean value and standard error of the mean, *paired t-test by bonferroni correc-
tion).  MyHC, myosin heavy chain.
Table 2. Statistical Analysis of Effect of Different Radiation Doses on the Laryngeal Muscles’ MyHC Isoform 
Expressions (Mean ± SD)
Muscle MyHC isoform       10 Gy 15 Gy 20 Gy
TA IIa*   0.16 ± 0.14
†  0.17 ± 0.11
†  0.03 ± 0.02
†
IIb  0.93 ± 0.08 0.88 ± 0.25 0.64 ± 0.29
IIx  0.79 ± 0.55  0.54 ± 0.15
†  0.38 ± 0.18
†
　 IIL  1.03 ± 0.17 1.05 ± 0.06  0.48 ± 0.17
†
  PCA I  0.87 ± 0.25 0.76 ± 0.21  0.71 ± 0.17
†
IIa*     0.001 ± 0.0002
†      0.001 ± 0.00004
†  0.05 ± 0.09
†
IIb   0.46 ± 0.01
†  0.43 ± 0.05
†  0.39 ± 0.15
†
IIx  0.65 ± 0.21  0.38 ± 0.15
†  0.36 ± 0.09
†
　 IIL   0.52 ± 0.12
†  0.40 ± 0.05
†  0.23 ± 0.11
†
CT I  0.97 ± 0.29  0.72 ± 0.14  0.52 ± 0.05
†
IIa* 0.058 ± 0.03
†  0.018 ± 0.009
†  0.005 ± 0.001
†
IIb  0.66 ± 0.11  0.52 ± 0.15
†  0.46 ± 0.09
†
　 IIx   0.51 ± 0.07
†  0.38 ± 0.10
†  0.30 ± 0.05
†
MyHC, myosin heavy chain; TA, thyroarytenoid muscle; PCA, posterior cricoarytenoid muscle; CT, cricothyroid muscle; ANOVA, analysis 
of variance.
*p < 0.05 in repeated measures ANOVA (post-hoc analysis by Turkey). 
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cles were examined at varying intervals after irradiation. 
The 20 Gy dose was chosen for this experiment because ir-
radiation of 20 Gy to rats is the biological dose equivalent 
of irradiation of 60 Gy to humans.14,15 
For the effect of the radiation dose, almost all the MyHC 
isoform expressions decreased, according to a radiation 
dose from 10 up to 20 Gy, in all the TA, PCA, and CT mus-
cles, and especially, the MyHC IIa expression was marked-
ly decreased in all three muscles. The statistical analysis us-
ing repeated measures of ANOVA (post-hoc analysis by 
Turkey) revealed that the MyHC IIa expression was signifi-
cantly decreased compared to the expressions of the other 
MyHC isoforms (p < 0.05) (Tables 2 and 3). The expres-
sions of almost all the MyHC isoforms in the TA, PCA, and 
CT muscles also gradually decreased over time. The TA, 
PCA, and CT muscle profiles were similar as the MyHC 
IIa expression declined rapidly from day 3 onwards and it 
continued to decrease for up to 12 weeks. But the decreas-
ing patterns of all the MyHC isoforms’ expressions showed 
little difference. So, it appears that while radiation generally 
decreases the laryngeal muscle expression of almost all the 
MyHC isoforms, the various muscles differ in their re-
sponse to radiation, and perhaps because they vary in mus-
cle function. There have not been any previous studies that 
have focused on the change of the MyHC isoform expres-
sion in the laryngeal muscle after X-ray irradiation. Accord-
ing to a study on the change of the MyHC isoform expres-
expression in the PCA muscle (Fig. 2). The TA, PCA, and 
CT muscle profiles were similar to the MyHC IIa expres-
sion as it rapidly declined from day 3 onwards and contin-
ued to decrease for up to 12 weeks. The statistical analysis 
using repeated measures of ANOVA (post-hoc analysis by 
Turkey) revealed that the MyHC IIa expression significant-
ly decreased, as compared to the expressions of the other 
MyHC isoforms (p < 0.05) (Table 3).
DISCUSSION
Recent studies have investigated the MyHC isoforms that 
are expressed by rodent and human laryngeal muscles, 
while others studies have examined the effect of thyroid 
hormone modulation or denervation and reinnervation on 
the laryngeal MyHC isoform expression profiles.10-13 Here, 
we examined the effect of radiation therapy on these ex-
pression profiles. 
We first assessed the effect of different radiation doses. 
The radiation was delivered as a single dose so as to limit 
anesthesia-induced death. The rats were sacrificed 14 days 
later because it has been reported that acute side effects de-
velop within 2 weeks of irradiation, while chronic side ef-
fects start at about 2 weeks.3 In this study, we obtained re-
sults similar to Nagler’s study. In the second experiment, 20 
Gy was delivered as a single dose and the laryngeal mus-
Table 3. Statistical Analysis of Effect of 20 Gy Irradiation on the Laryngeal Muscles’ MyHC Isoform Expres-
sions Over Time (Mean ± SD)
Muscle MyHC isoform 3 days 2 weeks 4 weeks  12 weeks
TA IIa*  0.16 ± 0.03
†  0.03 ± 0.02
†  0.05 ± 0.02
† 0.04 ± 0.03
†
IIb 0.75 ± 0.24 0.64 ± 0.29 0.73 ± 0.20 0.62 ± 0.05
†
IIx  0.57 ± 0.19
†  0.38 ± 0.18
†  0.18 ± 0.06
† 0.17 ± 0.07
†
　 IIL  0.77 ± 0.15
†  0.48 ± 0.17
†  0.48 ± 0.17
† 0.43 ± 0.08
†
  PCA I 0.98 ± 0.30 0.78 ± 0.20  0.43 ± 0.09
† 0.57 ± 0.13
†
IIa*  0.005 ± 0.004
† 0.0531 ± 0.09
†    0.001 ± 0.0001
†   0.001 ± 0.0001
†
IIb 0.71 ± 0.32  0.39 ± 0.15
†  0.39 ± 0.09
† 0.30 ± 0.04
†
IIx 0.95 ± 0.41 0.86 ± 0.24  0.51 ± 0.18
† 0.51 ± 0.04
†
　 IIL  0.73 ± 0.18
† 0.70 ± 0.11
†  0.60 ± 0.19
† 0.19 ± 0.11
†
CT I 0.88 ± 0.11  0.55 ± 0.06
†  0.29 ± 0.19
† 0.38 ± 0.09
†
IIa*  0.009 ± 0.007
†  0.004 ± 0.001
†  0.009 ± 0.004
† 0.004 ± 0.004
†
IIb 0.98 ± 0.37  0.68 ± 0.07
†  0.35 ± 0.08
† 0.13 ± 0.03
†
　 IIx  0.56 ± 0.03
†  0.53 ± 0.10
†  0.22 ± 0.09
† 0.20 ± 0.04
†
MyHC, myosin heavy chain; TA, thyroarytenoid muscle; PCA, posterior cricoarytenoid muscle; CT, cricothyroid muscle; ANOVA, analysis 
of variance.
*p < 0.05 in repeated measures ANOVA (post-hoc analysis by Turkey). 
†p < 0.05 in paired t-test by bonferroni correction.Jin Pyeong Kim, et al.
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4. Gillette EL, Mahler PA, Powers BE, Gillette SM, Vujaskovic Z. 
Late radiation injury to muscle and peripheral nerves. Int J Radiat 
Oncol Biol Phys 1995;31:1309-18.
5. Adams GR, Caiozzo VJ, Haddad F, Baldwin KM. Cellular and 
molecular responses to increased skeletal muscle loading after ir-
radiation. Am J Physiol Cell Physiol 2002;283:C1182-95.
6. Shiotani A, Flint PW. Expression of extraocular-superfast-myosin 
heavy chain in rat laryngeal muscles. Neuroreport 1998;9:3639-42.
7. Shiotani A, Westra WH, Flint PW. Myosin heavy chain composi-
tion in human laryngeal muscles. Laryngoscope 1999;109:1521-4.
8. Toniolo L, Maccatrozzo L, Patruno M, Pavan E, Caliaro F, Rossi 
R, et al. Fiber types in canine muscles: myosin isoform expression 
and functional characterization. Am J Physiol Cell Physiol 2007; 
292:C1915-26.
9. Sokoloff AJ, Li H, Burkholder TJ. Limited expression of slow 
tonic myosin heavy chain in human cranial muscles. Muscle 
Nerve 2007;36:183-9.
10. Hoh JF. Laryngeal muscle fibre types. Acta Physiol Scand 2005; 
183:133-49.
11. Wu YZ, Baker MJ, Crumley RL, Caiozzo VJ. Single-fiber myosin 
heavy-chain isoform composition of rodent laryngeal muscle: 
modulation by thyroid hormone. Arch Otolaryngol Head Neck 
Surg 2000;126:874-80.
12. Li ZB, Lehar M, Nakagawa H, Hoh JF, Flint PW. Differential ex-
pression of myosin heavy chain isoforms between abductor and 
adductor muscles in the human larynx. Otolaryngol Head Neck 
Surg 2004;130:217-22.
13. Rhee HS, Lucas CA, Hoh JF. Fiber types in rat laryngeal muscles 
and their transformations after denervation and reinnervation. J 
Histochem Cytochem 2004;52:581-90.
14. Dubin MG, Feldman M, Ibrahim HZ, Tufano R, Evans SM, 
Rosenthal D, et al. Allograft dermal implant (AlloDerm) in a pre-
viously irradiated field. Laryngoscope 2000;110:934-7.
15. Potten CS, Booth D, Cragg NJ, Tudor GL, O’Shea JA, Booth C, 
et al. Cell kinetic studies in the murine ventral tongue epithelium: 
mucositis induced by radiation and its protection by pretreatment 
with keratinocyte growth factor (KGF). Cell Prolif 2002;35 Suppl 
1:32-47.
16. Phelan JN, Gonyea WJ. Effect of radiation on satellite cell activity 
and protein expression in overloaded mammalian skeletal muscle. 
Anat Rec 1997;247:179-88.
sion in rat leg muscle after irradiation, the expressions of 
MyHC I and IIa in the plantaris muscle increased after 25 
Gy irradiation, but the expressions of MyHC IIb and IIx de-
creased. It was also reported that in the soleus muscle, the 
expression of embryogenic MyHC decreased after 3,000 
rad exposure.5,16 
In summary, the laryngeal muscles responded differently 
to radiation, but they showed a time-dependent and long-
lasting decrease in the expression of almost all the MyHC 
isoforms. We also observed that the MyHC IIa expression 
decreased more noticeably in the TA, PCA, and CT mus-
cles than the expressions of the other MyHC isoforms, 
which suggests that the MyHC IIa isoform may be more 
sensitive to irradiation than the other MyHC isoforms.
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